First generic EpiPen gets FDA approval

The U.S. Food and Drug Administration has approved the first generic competitor to EpiPen and EpiPen Jr. for the emergency treatment of allergic reactions in adults and children.

Reports of EpiPen shortage unfounded, Mylan says

Despite reports of EpiPen shortages across the United States, one of the companies that manufactures the device said it is shipping the product -- "though supplies may vary from pharmacy to pharmacy."